kl-2120
·Code: KL-2120
kl-2120: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Luckwel Pharmaceuticals Inc. (LKYM) | Preclinical |
Get deeper analysis on kl-2120
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis